AU2002952524A0 - Epstein barr virus peptide epitopes - Google Patents
Epstein barr virus peptide epitopesInfo
- Publication number
- AU2002952524A0 AU2002952524A0 AU2002952524A AU2002952524A AU2002952524A0 AU 2002952524 A0 AU2002952524 A0 AU 2002952524A0 AU 2002952524 A AU2002952524 A AU 2002952524A AU 2002952524 A AU2002952524 A AU 2002952524A AU 2002952524 A0 AU2002952524 A0 AU 2002952524A0
- Authority
- AU
- Australia
- Prior art keywords
- barr virus
- peptide epitopes
- epstein barr
- virus peptide
- epstein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002952524A AU2002952524A0 (en) | 2002-11-07 | 2002-11-07 | Epstein barr virus peptide epitopes |
PCT/AU2003/001451 WO2004041849A1 (en) | 2002-11-07 | 2003-11-03 | Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
TW092130642A TW200416043A (en) | 2002-11-07 | 2003-11-03 | Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
AU2003277975A AU2003277975A1 (en) | 2002-11-07 | 2003-11-03 | Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
US10/533,726 US20070048329A1 (en) | 2002-11-07 | 2003-11-03 | Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
CN200380102880.3A CN1711279B (en) | 2002-11-07 | 2003-11-03 | Epstein Barr virus peptide epitopes, polyepitopes and delivery system therefor |
HK06104269.0A HK1084129A1 (en) | 2002-11-07 | 2006-04-07 | Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002952524A AU2002952524A0 (en) | 2002-11-07 | 2002-11-07 | Epstein barr virus peptide epitopes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002952524A0 true AU2002952524A0 (en) | 2002-11-21 |
Family
ID=28795914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002952524A Abandoned AU2002952524A0 (en) | 2002-11-07 | 2002-11-07 | Epstein barr virus peptide epitopes |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1711279B (en) |
AU (1) | AU2002952524A0 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101066990B (en) * | 2007-04-27 | 2010-07-07 | 郑州大学 | Antitumor CTL epitope peptide possessing population broad spectrum property |
EP2701735A4 (en) * | 2011-04-28 | 2014-11-26 | Internat Medica Foundation | Liquid vaccine preparations |
CN107001444B (en) * | 2014-12-17 | 2020-11-27 | 中国科学院广州生物医药与健康研究院 | T cell receptor for identifying EB virus short peptide |
CN112125959B (en) * | 2020-10-10 | 2022-07-29 | 中山大学肿瘤防治中心 | Peptide for inhibiting EB virus, DNA for coding peptide and application thereof |
-
2002
- 2002-11-07 AU AU2002952524A patent/AU2002952524A0/en not_active Abandoned
-
2003
- 2003-11-03 CN CN200380102880.3A patent/CN1711279B/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1711279B (en) | 2010-05-26 |
CN1711279A (en) | 2005-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1084129A1 (en) | Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor | |
PL371007A1 (en) | Macrocyclic peptides active against the hepatitis c virus | |
AU3328900A (en) | Influenza virus hemagglutinin-binding peptides | |
AU2003206862A1 (en) | Hepatitis b vaccines | |
AU2003290563A1 (en) | Leptin-related peptides | |
EP1578787A4 (en) | Novel chi-conotoxin peptides (-ii) | |
EP1558628A4 (en) | Antigenic peptides | |
AU2003294220A1 (en) | Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES | |
GB0100196D0 (en) | Peptides | |
AU2003228863A1 (en) | Immunogenic peptides | |
EP1499635B8 (en) | Teneurin c-terminal associated peptides (tcap) and uses thereof | |
AU2002952524A0 (en) | Epstein barr virus peptide epitopes | |
EP1394177A4 (en) | High density lipoprotein-reactive peptides | |
AU2003301865A1 (en) | Epitopes of hepatitis c virus | |
AU2003293807A1 (en) | Mhc class i restricted t-cell stimulating peptides from hepatitis b virus | |
GB0109438D0 (en) | Peptides | |
AU2003221569A1 (en) | Cd4+ t-lymphocyte-specific hepatitis c virus epitopes | |
AUPS084502A0 (en) | Anti-protozoal vaccine | |
AU2003276846A1 (en) | Thrombopoiesis-stimulating proteins having reduced immunogenicity | |
AU2003225479A1 (en) | Reporter-selectable hepatitis c virus replicon | |
AU2001278975A1 (en) | Alpha-conotoxin peptides | |
AU2003267971A1 (en) | Improved alphavirus vectors having attenuated virion structural proteins | |
AU2003901792A0 (en) | Epstein barr virus peptide epitopes, polyepitopes & delivery system therefor | |
AU2003240866A1 (en) | Antibodies, peptides and vaccines against hiv-1 virus | |
AU2002351795A1 (en) | Hepatitis x virus antigen |